Using smartphones for patient symptom reporting during and after radiotherapy
Routine Electronic Patient-reported Outcome Measures During and After Radiotherapy: A Randomized Controlled Study (REPROM)
This study is testing whether using smartphones for cancer patients to report their symptoms during and after radiotherapy can help doctors better manage their care and improve their quality of life.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 536 (estimated) |
| Ages | 19 Years and up |
| Sex | All |
| Sponsor | Yonsei University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Yongin-si) |
| Trial ID | NCT06598293 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of routine electronic patient-reported outcome measures (PROMs) collected via smartphones in cancer patients undergoing radiotherapy. Participants will self-report their symptoms at various intervals during and after treatment, allowing radiation oncologists to monitor and address these symptoms in real-time. The study aims to assess the feasibility and acceptability of this approach and its potential impact on improving patients' quality of life and health outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 with a confirmed cancer diagnosis who can use a smartphone and have an ECOG performance status of 0 or 1.
Not a fit: Patients with terminal cancer or cognitive impairments, as well as those unable to use a smartphone, may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could enhance symptom management and improve the quality of life for cancer patients undergoing radiotherapy.
How similar studies have performed: Other studies have shown promise in using electronic patient-reported outcomes to improve patient care, indicating that this approach is both relevant and potentially beneficial.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \> 18 * Histologically confirmed diagnosis of cancer * Eastern Cooperative Oncology Group (ECOG) 0 or 1 * The ability to own and use a smartphone Exclusion Criteria: * Terminal cancer * Cognitive impairment * Not using your smartphone
Where this trial is running
Yongin-si
- Yongin Severance Hospital — Yongin-si, South Korea (Recruiting)
Study contacts
- Principal investigator: Hwakyung BYUN, Phd — Severance Hospital
- Study coordinator: Hwakyung BYUN, Phd
- Email: hkbyun05@yuhs.ac
- Phone: 007981072098955
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.